(Q41277363)

29 September 2017

1 reference

title

Oral antidiabetic drug use in the elderly (English)

1 reference

29 September 2017

R Bressler

1

1 reference

PubMed ID

8972242

29 September 2017

D G Johnson

series ordinal

2

1 reference

29 September 2017

1 December 1996

1 reference

29 September 2017

1 reference

29 September 2017

9

1 reference

29 September 2017

6

1 reference

29 September 2017

418-437

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199609060-00005

29 September 2017

0 references

cites work

Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD.

1 reference

12 December 2020

Drug interactions and long-term antidiabetic therapy

1 reference

12 December 2020

The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.

1 reference

12 December 2020

Sucrose malabsorption in man after ingestion of alpha-glucosidehydrolase inhibitor

1 reference

12 December 2020

Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions

1 reference

12 December 2020

Which comes first in non-insulin-dependent diabetes mellitus: insulin resistance or beta-cell failure? Both come first.

1 reference

12 December 2020

Long-term comparative trial of glibenclamide and chlorpropamide in diet-failed, maturity-onset diabetics

1 reference

12 December 2020

The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: Dose-time-response relationships in man

1 reference

12 December 2020

Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus.

1 reference

12 December 2020

Alpha-glucoside hydrolase inhibition in diabetes

1 reference

12 December 2020

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

12 December 2020

Hyperglycemia decreases glucose uptake in type I diabetes.

1 reference

12 December 2020

[The relatively frequent incidence of severe sulfonylurea-induced hypoglycemia in the last 25 years in Switzerland. Results of 2 surveys in Switzerland in 1969 and 1984]

1 reference

12 December 2020

The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs

1 reference

12 December 2020

Improved metabolic profiles in insulin-treated diabetic patients given an alpha-glucosidehydrolase inhibitor

1 reference

12 December 2020

Role of metformin in treatment of diabetes mellitus

1 reference

12 December 2020

Insulin versus insulin plus sulfonylureas in type 2 diabetic patients with secondary failure to sulfonylureas

1 reference

12 December 2020

Hyperglycaemic effect of nifedipine

1 reference

12 December 2020

Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients.

1 reference

12 December 2020

How good is the statistical evidence against oral hypoglycemic agents?

1 reference

12 December 2020

Nibbling versus gorging: metabolic advantages of increased meal frequency

1 reference

12 December 2020

1 reference

12 December 2020

Effects of alpha-glucosidase inhibition on meal glucose tolerance and timing of insulin administration in patients with type I diabetes mellitus

1 reference

12 December 2020

Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination

1 reference

12 December 2020

Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function.

1 reference

12 December 2020

Combined use of guar and acarbose in reduction of postprandial glycaemia

1 reference

12 December 2020

A two-step model for development of non-insulin-dependent diabetes

1 reference

12 December 2020

Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use.

1 reference

12 December 2020

Metabolic Effects of Combined Sulphonylurea and Metformin Therapy in Maturity-Onset Diabetics

1 reference

12 December 2020

Disposition of metformin (N,N-dimethylbiguanide) in man.

1 reference

12 December 2020

Metabolic effects of reducing rate of glucose ingestion by single bolus versus continuous sipping

1 reference

12 December 2020

1 reference

12 December 2020

HDL metabolism in diabetes

1 reference

12 December 2020

Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes

1 reference

12 December 2020

Metformin kinetics in healthy subjects and in patients with diabetes mellitus

1 reference

12 December 2020

1 reference

12 December 2020

Oral hypoglycemic agents

1 reference

12 December 2020

Secondary failure of oral hypoglycaemic agents: frequency, possible causes, and management

1 reference

12 December 2020

Influence of verapamil on human glucose tolerance

1 reference

12 December 2020

Analysis of long-term experience with tolbutamide (orinase) in the management of diabetes

1 reference

12 December 2020

New therapeutic agents for the treatment of NIDDM.

1 reference

12 December 2020

Diabetes mellitus treated with chlorpropamide and tolbutamide. A four-year clinical study

1 reference

12 December 2020

Sulfonylureas. Why, which, and how?

1 reference

12 December 2020

Displacement of tolbutamide, glibencalmide and chlorpropamide from serum albumin by anionic drugs

1 reference

12 December 2020

Mechanism of chlorpropamide-induced antidiuresis in man: Evidence for release of ADH and enhancement of peripheral action

1 reference

12 December 2020

Oral hypoglycaemic agents. An update

1 reference

12 December 2020

The crux of the UGDP. Spurious results and biologically inappropriate data analysis

1 reference

12 December 2020

The disposal of an oral glucose load in patients with non-insulin-dependent diabetes

1 reference

12 December 2020

Comparative efficacy of metformin and glibenclamide in patients with non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians

1 reference

12 December 2020

Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents

1 reference

12 December 2020

Ciglitazone, a new hypoglycaemic agent. 3. Effect on glucose disposal and gluconeogenesis in vivo in C57BL/6J-ob/ob and -+/? mice

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update

1 reference

12 December 2020

alpha-Glucosidase inhibitors. New complex oligosaccharides of microbial origin

1 reference

12 December 2020

Genetic and environmental determinants of non‐insulin‐dependent diabetes mellitus (NIDDM)

1 reference

12 December 2020

Combination insulin-sulfonylurea therapy

1 reference

12 December 2020

Effect of metformin on glucose metabolism in the splanchnic bed

1 reference

12 December 2020

Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions

1 reference

12 December 2020

Genetic regulation of the kinetics of glucose-induced insulin release in man. Studies in families with diabetic and non-diabetic probands

1 reference

12 December 2020

Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents

1 reference

12 December 2020

U.K. prospective diabetes study. II. Reduction in HbA1c with basal insulin supplement, sulfonylurea, or biguanide therapy in maturity-onset diabetes. A multicenter study

1 reference

12 December 2020

Nine years' experience with tolbutamide in the treatment of diabetes

1 reference

12 December 2020

Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion

1 reference

12 December 2020

Insulin plus a Sulfonylurea Agent for Treating Type 2 Diabetes

1 reference

12 December 2020

Glibenclamide-associated hypoglycaemia: a report on 57 cases

1 reference

12 December 2020

The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion

1 reference

12 December 2020

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

1 reference

12 December 2020

Pathogenesis of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

1 reference

12 December 2020

Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control

1 reference

12 December 2020

Pharmacokinetic disposition of 14C-glyburide in patients with varying renal function

1 reference

12 December 2020

Primary prevention of non‐insulin‐dependent diabetes mellitus

1 reference

12 December 2020

Effect of oral hypoglycaemic agents on glucose tolerance in pancreatic diabetes

1 reference

12 December 2020

The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism?

1 reference

12 December 2020

Reduction of Insulin Resistance in Obese and/or Diabetic Animals by 5-[4-(1-Methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, Ciglitazone), a New Antidiabetic Agent

1 reference

12 December 2020

Oral hypoglycemic agents

1 reference

12 December 2020

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.

1 reference

12 December 2020

Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinemia and atherosclerosis

1 reference

12 December 2020

The effect of food on the bioavailability and pharmacodynamics of tolbutamide in diabetic patients

1 reference

12 December 2020

1 reference

12 December 2020

Drug-induced hypoglycemia. A review of 1418 cases.

1 reference

12 December 2020

Chlorpropamide-induced hyponatremia: incidence and risk factors

1 reference

12 December 2020

Drug Treatment of Hypertension in Patients With Diabetes Mellitus

1 reference

12 December 2020

Long-Term Experience with Sulfonylureas and Placebo

1 reference

12 December 2020

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients

1 reference

12 December 2020

Treatment of lipid disorders in diabetes mellitus

1 reference

12 December 2020

Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats

1 reference

12 December 2020

Oral antidiabetic agents. The emergence of alpha-glucosidase inhibitors

1 reference

12 December 2020

Action of the hypoglycemic sulfonyl compounds in hypophysectomized, adrenalectomized and depancreatized animals.

1 reference

12 December 2020

A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results

1 reference

12 December 2020

Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM.

1 reference

12 December 2020

Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.

1 reference

12 December 2020

The effect of cimetidine on tolbutamide kinetics

1 reference

12 December 2020

LONG-TERM USE OF CHLORPROPAMIDE IN DIABETES.

1 reference

12 December 2020

Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.

1 reference

12 December 2020

The effects of oral hypoglycaemic drugs on serum lipids and lipoproteins in non-insulin-dependent diabetes (NIDDM).

1 reference

12 December 2020

Metformin efficacy and tolerance in obese non-insulin dependent diabetics: a comparison of two dosage schedules

1 reference

12 December 2020

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

12 December 2020

Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Role of insulin resistance in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus

1 reference

12 December 2020

Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes.

1 reference

12 December 2020

Oral antidiabetic combination therapy with sulphonylureas and metformin.

1 reference

12 December 2020

Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs

1 reference

12 December 2020

Pharmacokinetics of metformin after intravenous and oral administration to man

1 reference

12 December 2020

Diabetes and atherosclerosis: an epidemiologic view

1 reference

12 December 2020

Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

1 reference

12 December 2020

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

12 December 2020

Incidence of severe sideeffects during therapy with sulfonylureas and biguanides.

1 reference

12 December 2020

Comparison of plasma insulin levels following administration of tolbutamide and glucose

1 reference

12 December 2020

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

12 December 2020

Epidemiology of diabetes mellitus among the elderly in the United States

1 reference

12 December 2020

Comparison of tolbutamide and metformin in elderly diabetic patients

1 reference

12 December 2020

Combined insulin-sulfonylurea therapy in treatment of NIDDM.

1 reference

12 December 2020

Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM.

1 reference

12 December 2020

Effect of discontinuation of biguanide therapy on metabolic control in maturity-onset diabetics

1 reference

12 December 2020

In vitro studies on the action of CS-045, a new antidiabetic agent

1 reference

12 December 2020

Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes.

1 reference

12 December 2020

Clinical profile of glimepiride

1 reference

12 December 2020

Effects of a Biguanide (Metformin) on Vitamin B12and Folic Acid Absorption and Intestinal Enzyme Activities

1 reference

12 December 2020

Pathogenesis of NIDDM--a disease of deficient insulin secretion

1 reference

12 December 2020

Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agents.

1 reference

12 December 2020

Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats

1 reference

12 December 2020

Double-blind evaluation of efficacy and tolerability of metformin in NIDDM.

1 reference

12 December 2020

Undesired effects of the sulphonylurea drugs.

1 reference

12 December 2020

Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients

1 reference

12 December 2020

Increased cytosolic calcium. A signal for sulfonylurea-stimulated insulin release from beta cells.

1 reference

12 December 2020

The status of metformin in Canada

1 reference

12 December 2020

Ciglitazone, a New Hypoglycemic Agent: I. Studies in ob/ob and db/db Mice, Diabetic Chinese Hamsters, and Normal and Streptozotocin-Diabetic Rats

1 reference

12 December 2020

Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide

1 reference

12 December 2020

Chlorpropamide hyponatremia: drug-induced inappropriate antidiuretic-hormone activity.

1 reference

12 December 2020

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

12 December 2020

Age as independent determinant of glucose tolerance

1 reference

12 December 2020

Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative.

1 reference

12 December 2020

Familial Clustering of Insulin Sensitivity

1 reference

12 December 2020

Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

1 reference

12 December 2020

Metformin in the treatment of obese diabetics

1 reference

12 December 2020

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects.

1 reference

12 December 2020

Regulation of hepatic glucose metabolism in humans

1 reference

12 December 2020

Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion

1 reference

12 December 2020

Comparison of metformin and chlorpropamide in non-obese, maturity-onset diabetics uncontrolled by diet

1 reference

12 December 2020

Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM.

1 reference

12 December 2020

Comparison of chlorpropamide and metformin treatment on weight and blood-glucose response of uncontrolled obese diabetics

1 reference

12 December 2020

Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes

1 reference

12 December 2020

Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide

1 reference

12 December 2020

The binding of sulphonylureas to serum albumin

1 reference

12 December 2020

Oral hypoglycaemic drugs: clinical pharmacology and therapeutic use.

1 reference

12 December 2020

Drug Interactions with Oral Sulphonylurea Hypoglycaemic Drugs

1 reference

12 December 2020

Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients.

1 reference

12 December 2020

Effect of ciglitazone on glucose uptake and insulin sensitivity in skeletal muscle of the obese (ob/ob) mouse: distinct insulin and glucocorticoid effects

1 reference

12 December 2020

The “Dawn Phenomenon” — A Common Occurrence in Both Non-Insulin-Dependent and Insulin-Dependent Diabetes Mellitus

1 reference

12 December 2020

Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man

1 reference

12 December 2020

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

1 reference

12 December 2020

Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.

1 reference

12 December 2020

Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy

1 reference

12 December 2020

Clinical pharmacology of oral antidiabetic agents (first of two parts).

1 reference

12 December 2020

Metformin and the sulphonylureas: the comparative risk

1 reference

12 December 2020

Comparison of combined therapies in treatment of secondary failure to glyburide

1 reference

12 December 2020

Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former type 2 diabetics with attenuated insulin secretion

1 reference

12 December 2020

Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats

1 reference

12 December 2020

Metformin-induced lactic acidosis in the presence of acute renal failure

1 reference

12 December 2020

Mechanisms of sulfonylurea-induced insulin release

1 reference

12 December 2020

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

1 reference

12 December 2020

Effects of alpha-glucosidase inhibition and viscous fibre on diabetic control and postprandial gut hormone responses

1 reference

12 December 2020

Metformin Associated Lactic Acidosis

1 reference

12 December 2020

Effect of age and environmental factors on glucose tolerance and insulin secretion in a worker population

1 reference

12 December 2020

UK prospective study of therapies of maturity-onset diabetes. I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year

1 reference

12 December 2020

The hypoglycemic sulfonamides: history and development of the problem from 1942 to 1955

1 reference

12 December 2020

Diarrhea and Metformin in a Diabetic Clinic

1 reference

12 December 2020

Pathogenesis of NIDDM. A balanced overview

1 reference

12 December 2020

Lipoprotein metabolism in diabetes mellitus

1 reference

12 December 2020

Beta cell function in long term NIDDM (type 2) patients and its relation to treatment.

1 reference

12 December 2020

Characterization of the sulfonylurea receptor on beta cell membranes

1 reference

12 December 2020

Dyslipidemia in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view

1 reference

12 December 2020

Signal transduction in insulin secretion: comparison between fuel stimuli and receptor agonists

1 reference

12 December 2020

Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM.

1 reference

12 December 2020

Sites of metformin-stimulated glucose metabolism

1 reference

12 December 2020

Metformin compared with tolbutamide in the treatment of maturity-onset diabetes mellitus

1 reference

12 December 2020

Management of the Adult Onset Diabetic with Sulfonylurea Drug Failure

1 reference

12 December 2020

Hypoglycaemic agents which do not release insulin

1 reference

12 December 2020

Diabetes and cardiovascular disease. The Framingham study

1 reference

12 December 2020

The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man

1 reference

12 December 2020

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Effect of physical activity on age-related glucose intolerance.

1 reference

12 December 2020

Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone

1 reference

12 December 2020

Plasma insulin response among Nauruans. Prediction of deterioration in glucose tolerance over 6 yr

1 reference

12 December 2020

Role of metformin accumulation in metformin-associated lactic acidosis

1 reference

12 December 2020

Obesity and diabetes in “the land of milk and honey”

1 reference

12 December 2020

Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.

1 reference

12 December 2020

Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM?

1 reference

12 December 2020

Interaction of glipizide with human serum albumin

1 reference

12 December 2020

Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group

1 reference

12 December 2020

Plasma chlorpropamide: a critical factor in chlorpropamide-alcohol flush

1 reference

12 December 2020

Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr.

1 reference

12 December 2020

LONG-TERM OBSERVATIONS ON ORAL HYPOGLYCEMIC AGENTS IN DIABETES; THE EFFECT OF CARBUTAMIDE AND TOLBUTAMIDE

1 reference

12 December 2020

Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study.

1 reference

12 December 2020

Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes

1 reference

12 December 2020

Combination therapy with insulin and sulfonylureas for type II diabetes

1 reference

12 December 2020

Sulfonylurea receptors, ion channels, and fruit flies

1 reference

12 December 2020

Bioavailability of metformin. Comparison of solution, rapidly dissolving tablet, and three sustained release products

1 reference

12 December 2020

What is the benefit of increasing the sulfonylurea dose?

1 reference

12 December 2020

Glimepiride for NIDDM

1 reference

12 December 2020

Biguanides and sulfonylureas as combination therapy in NIDDM.

1 reference

12 December 2020

Ineffectiveness of sulfonylureas in alloxan diabetic rats

1 reference

12 December 2020

Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.

1 reference

12 December 2020

Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Cellular mechanism of action of metformin

1 reference

12 December 2020

Bedtime insulin for suppression of overnight free-fatty acid, blood glucose, and glucose production in NIDDM

1 reference

12 December 2020

Sulfonylureas do not affect insulin binding or glycemic control in insulin-dependent diabetics

1 reference

12 December 2020

An epidemiological perspective of the relationship between physical activity and NIDDM: from activity assessment to intervention

1 reference

12 December 2020

Alterations in glucose metabolism in the elderly patient with diabetes

1 reference

12 December 2020

Metformin and lactic acidosis--a reminder

1 reference

12 December 2020

New oral thiazolidinedione antidiabetic agents act as insulin sensitizers

1 reference

12 December 2020

Glucosidase inhibition. A new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia

1 reference

12 December 2020

Tolbutamide does not alter insulin requirement in Type 1 (insulin-dependent) diabetes

1 reference

12 December 2020

10.2165/00002512-199609060-00005

Identifiers

DOI

1 reference

PubMed ID

8972242

Dimensions Publication ID

29 September 2017

0 references

1 reference

PubMed ID

8972242